Galenica AG

Pharmaceuticals
Switzerland
Earnings Per Share Growth (%)5.79%
Cost of Goods Sold (US$ Millions)$2,350
Current Liabilities (US$ Millions)$809
Total Assets (US$ Millions)$1,432
Long Term Debt$673
Return on Equity17.58%
Revenue (US$ Millions)$3,973
Total Company Assets$3,665
Revenue Growth (%)7.47%
Net Income (US$ Millions)$303
Earnings Per Share (US$)$5.79
Total Equity (US$ Millions)$1,892
Profit Margin (%)7.63%
Debt To Equity Ratio (%)0.36%
Inventory Turnover$386